Vunakizumab Uses, Dosage, Side Effects and more
Vunakizumab is under investigation in clinical trial NCT03463187 (Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis).
| Trade Name | Vunakizumab |
| Generic | Vunakizumab |
| Vunakizumab Other Names | Vunakizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
